What is the equity of Arovella Therapeutics this year?
Arovella Therapeutics has equity of 11.23 M AUD this year.
Arovella Therapeutics Equity 2024
Arovella Therapeutics Equity
11.23 M AUD
Ticker
ALA.AX
ISIN
AU0000182784
WKN
A3C575
In 2024, Arovella Therapeutics's equity was 11.23 M AUD, a 47.41% increase from the 7.62 M AUD equity in the previous year.
Arovella Therapeutics Aktienanalyse
What does Arovella Therapeutics do?
Arovella Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Arovella Therapeutics's Equity
Arovella Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Arovella Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Arovella Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Arovella Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Arovella Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Arovella Therapeutics stock
What was the equity of Arovella Therapeutics compared to the previous year?
The equity of Arovella Therapeutics has increased/decreased by 47.41% increased compared to the previous year.
What impact does a high equity have on investors of Arovella Therapeutics?
A high equity is advantageous for investors of Arovella Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Arovella Therapeutics?
A low equity can be a risk for investors of Arovella Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Arovella Therapeutics affect the company?
An increase in equity of Arovella Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Arovella Therapeutics affect the company?
A reduction in equity of Arovella Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Arovella Therapeutics?
Some factors that can affect the equity of Arovella Therapeutics include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Arovella Therapeutics so important for investors?
The equity of Arovella Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Arovella Therapeutics take to change the equity?
To change equity, Arovella Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Arovella Therapeutics pay?
Over the past 12 months, Arovella Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arovella Therapeutics is expected to pay a dividend of 0 AUD.
What is the dividend yield of Arovella Therapeutics?
The current dividend yield of Arovella Therapeutics is .
When does Arovella Therapeutics pay dividends?
Arovella Therapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Arovella Therapeutics?
Arovella Therapeutics paid dividends every year for the past 0 years.
What is the dividend of Arovella Therapeutics?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Arovella Therapeutics located?
Arovella Therapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Arovella Therapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Arovella Therapeutics from 9/22/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.
When did Arovella Therapeutics pay the last dividend?
The last dividend was paid out on 9/22/2024.
What was the dividend of Arovella Therapeutics in the year 2023?
In the year 2023, Arovella Therapeutics distributed 0 AUD as dividends.
In which currency does Arovella Therapeutics pay out the dividend?
The dividends of Arovella Therapeutics are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Arovella Therapeutics
Our stock analysis for Arovella Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arovella Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Arovella Therapeutics Revenue
- Arovella Therapeutics Net Income
- Arovella Therapeutics P/E
- Arovella Therapeutics P/S
- Arovella Therapeutics EBIT
- Arovella Therapeutics Dividend
- Arovella Therapeutics Stocks
- Arovella Therapeutics Market capitalization
- Arovella Therapeutics Debt
- Arovella Therapeutics Liabilities
- Arovella Therapeutics Equity
- Arovella Therapeutics AAQS
- Arovella Therapeutics Employees
- Arovella Therapeutics ROE
- Arovella Therapeutics ROA
- Arovella Therapeutics ROCE